692 related articles for article (PubMed ID: 9128983)
21. Synergistic interactions of the two classes of ligand, sialyl-Lewis(a/x) fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designs.
Galustian C; Childs RA; Stoll M; Ishida H; Kiso M; Feizi T
Immunology; 2002 Mar; 105(3):350-9. PubMed ID: 11918697
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of melanoma-associated gangliosides in cancer patients.
Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
[TBL] [Abstract][Full Text] [Related]
23. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.
Helling F; Shang A; Calves M; Zhang S; Ren S; Yu RK; Oettgen HF; Livingston PO
Cancer Res; 1994 Jan; 54(1):197-203. PubMed ID: 8261439
[TBL] [Abstract][Full Text] [Related]
24. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
25. Anti-Sia-lb (anti-Gd) cold agglutinins bind the domain NeuNAc alpha2-3Gal in sialyl Lewis(x), sialyl Lewis(a), and related carbohydrates on nucleated cells and in soluble cancer-associated mucins.
Gallart T; Roelcke D; Blay M; Pereira A; Martínez A; Massó O; Viñas O; Cid M; Esparza J; Molina R; Barceló J
Blood; 1997 Aug; 90(4):1576-87. PubMed ID: 9269776
[TBL] [Abstract][Full Text] [Related]
26. Gangliosides expressed on breast cancer cells are E-selectin ligands.
Shirure VS; Henson KA; Schnaar RL; Nimrichter L; Burdick MM
Biochem Biophys Res Commun; 2011 Mar; 406(3):423-9. PubMed ID: 21329670
[TBL] [Abstract][Full Text] [Related]
27. Identification of a major carbohydrate capping group of the L-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis X.
Mitsuoka C; Sawada-Kasugai M; Ando-Furui K; Izawa M; Nakanishi H; Nakamura S; Ishida H; Kiso M; Kannagi R
J Biol Chem; 1998 May; 273(18):11225-33. PubMed ID: 9556613
[TBL] [Abstract][Full Text] [Related]
28. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide.
Foxall C; Watson SR; Dowbenko D; Fennie C; Lasky LA; Kiso M; Hasegawa A; Asa D; Brandley BK
J Cell Biol; 1992 May; 117(4):895-902. PubMed ID: 1374413
[TBL] [Abstract][Full Text] [Related]
29. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells.
Fuster MM; Brown JR; Wang L; Esko JD
Cancer Res; 2003 Jun; 63(11):2775-81. PubMed ID: 12782582
[TBL] [Abstract][Full Text] [Related]
30. Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells.
Ohyama C; Tsuboi S; Fukuda M
EMBO J; 1999 Mar; 18(6):1516-25. PubMed ID: 10075923
[TBL] [Abstract][Full Text] [Related]
31. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy.
Ravindranath NM; Nishimoto K; Chu K; Shuler C
Anticancer Res; 2000; 20(1A):21-6. PubMed ID: 10769630
[TBL] [Abstract][Full Text] [Related]
32. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells.
Zhang K; Baeckström D; Brevinge H; Hansson GC
J Cell Biochem; 1996 Mar; 60(4):538-49. PubMed ID: 8707893
[TBL] [Abstract][Full Text] [Related]
33. Normal cellular prion protein is a ligand of selectins: binding requires Le(X) but is inhibited by sLe(X).
Li C; Wong P; Pan T; Xiao F; Yin S; Chang B; Kang SC; Ironside J; Sy MS
Biochem J; 2007 Sep; 406(2):333-41. PubMed ID: 17497959
[TBL] [Abstract][Full Text] [Related]
34. E-selectin binding by pancreatic tumor cells is inhibited by cancer sera.
Sawada T; Ho JJ; Chung YS; Sowa M; Kim YS
Int J Cancer; 1994 Jun; 57(6):901-7. PubMed ID: 7515860
[TBL] [Abstract][Full Text] [Related]
35. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
Ravindranath MH; Morton DL; Irie RF
Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
[TBL] [Abstract][Full Text] [Related]
36. The discovery, biology, and drug development of sialyl Lea and sialyl Lex.
Magnani JL
Arch Biochem Biophys; 2004 Jun; 426(2):122-31. PubMed ID: 15158662
[TBL] [Abstract][Full Text] [Related]
37. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells.
Fukuda MN; Ohyama C; Lowitz K; Matsuo O; Pasqualini R; Ruoslahti E; Fukuda M
Cancer Res; 2000 Jan; 60(2):450-6. PubMed ID: 10667600
[TBL] [Abstract][Full Text] [Related]
38. Quantifying rolling adhesion with a cell-free assay: E-selectin and its carbohydrate ligands.
Brunk DK; Hammer DA
Biophys J; 1997 Jun; 72(6):2820-33. PubMed ID: 9168056
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of sialyl Le(a) and sialyl Le(x) antigen in oral squamous cell carcinoma: the association of sialyl Le(a) expression with the metastatic potential.
Kurahara S; Shinohara M; Ikebe T; Nakamura S; Hiraki A; Sasaki M; Beppu M; Shirasuna K
Head Neck; 1999 Jul; 21(4):330-7. PubMed ID: 10376753
[TBL] [Abstract][Full Text] [Related]
40. Induction of antibodies to a tumor-associated antigen by immunization with a whole melanoma cell vaccine.
Euhus DM; Gupta RK; Morton DL
Cancer Immunol Immunother; 1989; 29(4):247-54. PubMed ID: 2752392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
